Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$0.57 - $0.99 $28,499 - $49,500
-50,000 Reduced 12.41%
353,003 $292,000
Q4 2020

Feb 08, 2021

SELL
$1.08 - $8.2 $28,103 - $213,380
-26,022 Reduced 6.07%
403,003 $3.3 Million
Q3 2020

Nov 13, 2020

BUY
$0.95 - $1.42 $12,360 - $18,475
13,011 Added 3.13%
429,025 $502,000
Q2 2020

Aug 03, 2020

SELL
$0.63 - $1.7 $190,419 - $513,830
-302,253 Reduced 42.08%
416,014 $503,000
Q1 2020

Apr 17, 2020

BUY
$0.67 - $1.85 $202,509 - $559,168
302,253 Added 72.65%
718,267 $506,000
Q3 2019

Oct 29, 2019

SELL
$1.74 - $2.83 $16,223 - $26,386
-9,324 Reduced 2.19%
416,014 $932,000
Q1 2019

May 09, 2019

SELL
$0.78 - $2.01 $54,320 - $139,980
-69,642 Reduced 14.07%
425,338 $846,000
Q4 2018

Feb 08, 2019

SELL
$0.62 - $2.25 $55,037 - $199,732
-88,770 Reduced 15.21%
494,980 $341,000
Q2 2018

Aug 14, 2018

BUY
$1.73 - $3.35 $1.01 Million - $1.96 Million
583,750 New
583,750 $1.01 Million

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Arnhold LLC Portfolio

Follow Arnhold LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.